Weight loss drugs can halve heart patients’ risk of early death, study finds
An expert said more evidence would be required before doctors could recommend rolling out weight loss drugs to heart patients specifically to cut their risk.
Weight loss drugs can reduce by half the risk of heart patients being hospitalised or dying early, according to the largest study of its kind.
The class of drugs, known as GLP-1 agonists, have been found to offer “dramatic benefits” to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause.
